CLINICAL_TRIALS trial_result · 2017-04-24

Clinical Trial Update: Ubiquinol (Reduced COQ10) for Patients With Sepsis [Phase 2]

Phase 2 trial evaluating ubiquinol (reduced CoQ10) for sepsis has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Sepsis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-24